News
by BSCN
March 5, 2025
Through Libre’s decentralized gateway on Injective, investors can now engage in secondary trading, collateralized lending, and portfolio margining, unlocking new efficiencies in DeFi.
Libre, a leading technology infrastructure platform, has partnered with Nomura’s Laser Digital to bring institutional investment funds on-chain via Injective, a high-performance Layer 1 blockchain.
This integration represents a major step forward in real-world asset (RWA) tokenization, making traditional finance (TradFi) more accessible, liquid, and interoperable within decentralized finance (DeFi). Notably, institutional investors can now access tokenized funds from BlackRock, Brevan Howard, and Hamilton Lane—all within Libre’s decentralized application (dApp) on Injective.
The partnership between Libre and Injective enables institutional and accredited investors to seamlessly access some of the world's largest financial firms through blockchain-based tokenization.
Laser Carry Fund (LCF) – A market-neutral digital asset strategy by Nomura’s Laser Digital, leveraging funding rates and staking yields.
Libre's real-world asset (RWA) tokenization transforms traditional financial instruments into blockchain-based tokens, improving liquidity, transparency, and efficiency.
This approach eliminates inefficiencies found in traditional finance, offering:
"Our collaboration with Injective isn’t just about bringing institutional funds on-chain; it’s about redefining access to capital markets through Web3 infrastructure." — Dr. Avtar Sehra, CEO of Libre
Injective is emerging as the go-to blockchain for institutional finance. Its high-performance infrastructure offers:
"We are pleased to tokenize the Laser Carry Fund (LCF) on Injective, leveraging its decentralized order book and minimal transaction fees to streamline institutional tokenization." — Florent Jouanneau, Partner, Laser Digital
This integration allows trillions in institutional capital to flow into blockchain ecosystems, pushing DeFi toward mass institutional adoption.
Adding to Injective’s momentum, Deutsche Telekom MMS, a subsidiary of Deutsche Telekom, recently joined Injective’s validator set.
Injective’s commitment to bridging TradFi and DeFi is further reinforced by its recent launch of an on-chain TradFi index via Helix.
A decentralized index that tracks hundreds of the largest publicly traded equities.
Users can trade stocks 24/7 with up to 25X leverage.
Major Companies in the Index Include:
Disclaimer
Disclaimer: The views expressed in this article do not necessarily represent the views of BSCN. The information provided in this article is for educational and entertainment purposes only and should not be construed as investment advice, or advice of any kind. BSCN assumes no responsibility for any investment decisions made based on the information provided in this article. If you believe that the article should be amended, please reach out to the BSCN team by emailing [email protected].
Latest News
March 17, 2025
Pi Network's PI Token: Analysis and Review
March 17, 2025
Hedera and the HBAR Token: Full Analysis & Review
March 17, 2025
Do AI Agents Need a Token? CZ Weighs In
March 17, 2025
New Pi Network Features for Pi Day 2025
March 17, 2025
What’s Fueling PancakeSwap’s Sudden Surge in Trading Volume?
March 17, 2025
How Much Bitcoin Does North Korea’s Lazarus Group Own?
March 17, 2025
LIBRA Token Co-Creator Hayden Davis' Alleged New Token: What We Know
March 15, 2025
Weekly Article Recap: 3/10-3/14